We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Aug 2020 - 08 Aug 2020

Illustration

Coronavirus Causes Depletion of Key Immune Cells, Find Recent Studies

Recent studies have found that similar to HIV, SARS-CoV-2 can also deplete key immune cells in COVID-19 patients, suggesting that a cocktail of drugs could be required to treat patients infected with the coronavirus, according to a report by the New York Times. More...
31 Jul 2020
Illustration

US COVID-19 Testing Supply Data Reveal One Million Tests Being Shipped Per Day

Data released by a US national COVID-19 diagnostic supply registry shows that over one million SARS-CoV-2 tests are being shipped every day. More...
31 Jul 2020
Image: Allplex 2019-nCoV Assay (Photo courtesy of Seegene, Inc.)

Seegene Allplex 2019-nCoV Assay (SARS-CoV-2) Granted Expanded FDA Emergency Use Authorization

Seegene, Inc. (Seoul, South Korea) has been granted expanded Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its Allplex 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease. More...
31 Jul 2020
Illustration

INOVIO's COVID-19 DNA Vaccine Becomes Only Vaccine to Demonstrate Long-Term Protection in Monkeys 13 Weeks from Vaccination

A COVID-19 DNA vaccine targeting SARS-CoV-2 has proved effective in protecting non-human primates (NHPs; specifically rhesus macaques) from live virus challenge 13 weeks after the last vaccination, with the protective results mediated by memory T and B cell immune responses from the vaccination. More...
31 Jul 2020
Illustration

World’s First COVID-19 Vaccine to Be Launched by Russia on August 10-12

Russia is all set to register a coronavirus vaccine by August 10-12, paving the way for what would be the first official approval of an inoculation against COVID-19 in the world, according to a Bloomberg report. More...
31 Jul 2020
Image: Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-Clinical Studies (Photo courtesy of Johnson & Johnson)

Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-Clinical Studies

Johnson & Johnson’s (New Brunswick, NJ, USA) lead vaccine candidate has successfully protected monkeys against infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies. More...
31 Jul 2020
Image: The Ellipsys Vascular Access System (Photo courtesy of Avenu Medical)

Vascular Access System Creates Durable AVF for Hemodialysis

A novel device uses a small needle puncture and a catheter to create a percutaneous arteriovenous fistula (pAVF) for end-stage renal disease (ESRD) patients who require hemodialysis. More...
30 Jul 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.